Pharma distributors carry the commercial risk when a shipment arrives late, a dossier is incomplete or a batch fails inspection. Whether you supply hospitals in Nigeria, pharmacy chains in Peru or wholesalers in Vietnam, your Indian supplier decides how smoothly that goes. This guide sets out what to verify before you sign.
A distributor’s reputation rests on repeat supply. Pharmacies, tender buyers and hospital procurement teams do not forgive stock-outs, short-dated batches or missing paperwork, so the supplier relationship has to be built on more than a good quote. In practice most distributors need four things: a licensed manufacturing source, a consistent product range, documents that satisfy their own regulator, and predictable lead times.
India exports a very wide range of formulations, which is exactly why vetting matters. Vinix BioPharma works with pharma distributors across Africa, Latin America and Asia, sourcing from certified manufacturers and handling export documentation, so the buyer deals with one accountable partner instead of several factories.
Consistency between batches is the other quiet requirement. If packaging, labelling or artwork changes without notice, your pharmacy customers notice before you do. Ask how the supplier controls change and how it informs you of one.
Smaller distributors who prefer not to hold stock can also look at pharmacy dropshipping support, where orders ship directly to the end pharmacy.
Most import markets will not clear a product without registration. Before listing any molecule, confirm that your supplier can provide the technical file your authority expects, and how quickly it answers regulator queries during review.
Requirements differ by country. Confirm the current list with your national regulator before ordering, and ask your supplier to share batch documents in advance.
GMP is a baseline, not a guarantee. Ask which plant will make your product, when it was last inspected and whether the certificate covers that dosage form. The World Health Organization publishes quality guidance that many regulators reference, which gives you a neutral benchmark when you review a supplier’s claims.
Compare batch numbers, expiry dates and quantities on the cartons with the packing list and certificate of analysis before releasing stock to customers. Report any discrepancy to the supplier immediately and keep photographs for your records.
The agreement decides how much protection you have after investing in registration and market development. These are the common structures:
| Model | Suits | Agree in writing |
|---|---|---|
| Exclusive | Distributors funding registration in a defined territory | Territory, minimum order commitment, term |
| Non-exclusive | Wholesalers testing a new product line | Product list, batch allocation, lead time |
| Tender supply | Public-sector and hospital contracts | Delivery schedule, documents, shelf-life |
Whichever route you choose, record who owns the registration, what happens if supply is interrupted and how quality complaints are handled. These clauses cost nothing to agree early and a great deal to argue about later.
Ask for realistic production and dispatch timelines, the Incoterms on offer, packaging suited to your climate and how temperature-sensitive lines are handled. Build your safety stock around the supplier’s real lead time, not the best case, and review it after the first two or three shipments.
Many distributors sign first and test later. A structured first month shows you how a supplier behaves before real volume is committed.
A supplier who treats this first month seriously will usually treat later orders the same way. A supplier who resists checks early is telling you something useful.
Share your target market and product list and our export team will outline the documents, models and timelines.
Typically a dossier, CoPP, WHO-GMP certificate, manufacturing licence and a batch certificate of analysis. The exact list depends on the importing country.
Yes, but one export partner that sources from certified plants simplifies documents, consolidation and accountability.
Not always. It matters most when you fund registration in a territory. For testing a new line, a non-exclusive arrangement is often enough.
Agree a minimum remaining shelf-life at dispatch and check expiry dates against the packing list when cartons arrive.
Export documentation, regulatory and supply specialists at Vinix BioPharma, a WHO-GMP generic medicines manufacturer and exporter from Mumbai, India, serving importers, distributors and tender buyers in Latin America, Africa and the CIS.
Tell us your products and destination country. Our export team replies with documents and shipping options. B2B enquiries only.
or call +91 96531 13180
Dossiers, CoPP and export documents for your market. Bulk supply, dropshipping and private label.
